Xiaolong Cheng

1.7k total citations
28 papers, 325 citations indexed

About

Xiaolong Cheng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaolong Cheng has authored 28 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xiaolong Cheng's work include Esophageal Cancer Research and Treatment (4 papers), Cancer-related gene regulation (4 papers) and Extracellular vesicles in disease (3 papers). Xiaolong Cheng is often cited by papers focused on Esophageal Cancer Research and Treatment (4 papers), Cancer-related gene regulation (4 papers) and Extracellular vesicles in disease (3 papers). Xiaolong Cheng collaborates with scholars based in China, United States and Hong Kong. Xiaolong Cheng's co-authors include Yongping Cui, Shih‐Hsin Lu, Pengzhou Kong, Zheng Shen, Thomas M. Guadagno, Ce Zhang, Fang Wang, Yuanfang Zhai, Jian Yang and Yanyan Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and European Journal of Pharmacology.

In The Last Decade

Xiaolong Cheng

23 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolong Cheng China 12 210 91 74 73 35 28 325
Bi‐Jun Huang China 10 248 1.2× 106 1.2× 44 0.6× 126 1.7× 75 2.1× 36 382
Dae Hwa Choi South Korea 10 257 1.2× 84 0.9× 41 0.6× 96 1.3× 43 1.2× 13 368
Shiyi Yu China 12 257 1.2× 97 1.1× 49 0.7× 67 0.9× 33 0.9× 21 335
Alexander Bank United States 7 209 1.0× 113 1.2× 53 0.7× 55 0.8× 30 0.9× 11 337
Chunjuan Zhao China 9 257 1.2× 46 0.5× 34 0.5× 194 2.7× 44 1.3× 12 360
Stacey L. Lehman United States 7 262 1.2× 81 0.9× 120 1.6× 89 1.2× 32 0.9× 12 394
Veronica Yee-Law Leong Hong Kong 6 338 1.6× 155 1.7× 53 0.7× 115 1.6× 18 0.5× 6 478
Meghan M. Joly United States 10 222 1.1× 72 0.8× 30 0.4× 62 0.8× 30 0.9× 14 337
Langzhu Tan United States 8 252 1.2× 77 0.8× 31 0.4× 53 0.7× 29 0.8× 9 362
Linfei Hu China 13 268 1.3× 104 1.1× 27 0.4× 119 1.6× 68 1.9× 34 451

Countries citing papers authored by Xiaolong Cheng

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Cheng more than expected).

Fields of papers citing papers by Xiaolong Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Cheng. The network helps show where Xiaolong Cheng may publish in the future.

Co-authorship network of co-authors of Xiaolong Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Cheng. A scholar is included among the top collaborators of Xiaolong Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Cheng. Xiaolong Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Heng, Tong Zhou, Yanfang Yang, et al.. (2025). LncRNADANCR Promotes ESCC Progression and Function as ceRNA to Regulate DDIT3 Expression by Sponging microRNA‐3193. Cancer Science. 116(5). 1324–1338. 1 indexed citations
3.
5.
Wang, Lu, Huijuan Liu, Yiqian Liu, et al.. (2024). miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39. Cancer Gene Therapy. 31(7). 1060–1069. 2 indexed citations
6.
Wang, Lu, Huijuan Liu, Guohui Chen, et al.. (2024). Bubble Ticket Trip: Exploring the Mechanism of miRNA Sorting into Exosomes and Maintaining the Stability of Tumor Microenvironment. International Journal of Nanomedicine. Volume 19. 13671–13685. 1 indexed citations
7.
Xu, Xiaoqin, Xin Yang, Xue Liu, et al.. (2022). The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 21. 2213824993–2213824993. 3 indexed citations
8.
Zou, Binbin, et al.. (2022). Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma. Frontiers in Molecular Biosciences. 8. 792779–792779. 8 indexed citations
9.
Zhai, Yuanfang, Pengzhou Kong, Ling Zhang, et al.. (2022). FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma. Molecular and Cellular Biochemistry. 477(12). 2689–2702. 18 indexed citations
10.
Yang, Bin, Huijuan Liu, Yanghui Bi, et al.. (2020). MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma. International Journal of Medical Sciences. 17(13). 2013–2023. 27 indexed citations
11.
Yang, Jian, Tianyi Guo, Liang Xiao, et al.. (2020). Cadmium inhibits apoptosis of human esophageal epithelial cells by upregulating CDK6. Ecotoxicology and Environmental Safety. 205. 111146–111146. 7 indexed citations
13.
Ma, Yanchun, Yi Wang, Lu Wang, et al.. (2019). Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway. European Journal of Pharmacology. 851. 43–51. 40 indexed citations
14.
Hu, Xiao, Yuanfang Zhai, Ruyi Shi, et al.. (2018). FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma. Oncology Reports. 39(5). 2136–2146. 23 indexed citations
15.
Shi, Ruyi, Heyang Cui, Yanghui Bi, et al.. (2015). Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma. Oncology Letters. 9(5). 2249–2255. 20 indexed citations
16.
Cheng, Xiaolong, et al.. (2012). Studies on characteristics of root distribution of ‘Korla's Xiangli’. Guoshu xuebao. 29(6). 1036–1039. 2 indexed citations
17.
Cheng, Xiaolong, Heyang Cui, Zhenxiang Zhao, et al.. (2012). Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma. Oncogene. 32(6). 713–723. 28 indexed citations
18.
Cui, Yongping, Xiaolong Cheng, Ce Zhang, et al.. (2010). Degradation of the Human Mitotic Checkpoint Kinase Mps1 Is Cell Cycle-regulated by APC-cCdc20 and APC-cCdh1 Ubiquitin Ligases*. Journal of Biological Chemistry. 285(43). 32988–32998. 36 indexed citations
19.
Cheng, Xiaolong, Zheng Shen, Litian Yin, Shih‐Hsin Lu, & Yongping Cui. (2009). ECRG2 Regulates Cell Migration/Invasion through Urokinase-type Plasmin Activator Receptor (uPAR)/β1 Integrin Pathway. Journal of Biological Chemistry. 284(45). 30897–30906. 23 indexed citations
20.
Cheng, Xiaolong, et al.. (2007). ECRG2 Disruption Leads to Centrosome Amplification and Spindle Checkpoint Defects Contributing Chromosome Instability. Journal of Biological Chemistry. 283(9). 5888–5898. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026